Early Childhood Attention Battery: Italian adaptation and new expanded normative data.


Journal

Early human development
ISSN: 1872-6232
Titre abrégé: Early Hum Dev
Pays: Ireland
ID NLM: 7708381

Informations de publication

Date de publication:
05 2020
Historique:
received: 03 12 2019
revised: 25 02 2020
accepted: 03 03 2020
pubmed: 18 3 2020
medline: 27 8 2021
entrez: 18 3 2020
Statut: ppublish

Résumé

The Early Childhood Attention Battery (ECAB) has been used to assess three different components of attention in preschool children, namely, selective, sustained and attentional control. The aim of the study was: I) to adapt the ECAB to the Italian language; II) to collect Italian reference data using the translated version and III) to expand the available reference data using 6-month age intervals. The adaptation of the ECAB to Italian language and the collection of Italian reference data was performed in four phases: translation and identification of the manual and subtests that needed adaptation; interobserver reliability and feasibility of the Italian version; application of the Italian ECAB; statistical analysis. The ECAB was performed on a low risk population between 3 and 5 years, 11 months. Statistical analysis was conducted subdividing the cohort in 6-month age groups. The final cohort included 300 low-risk typically developing children. The assessment was well accepted and enjoyed by most of the children except for some in the youngest group who refused to complete all of the tests. Our data showed a progressive improvement in attention across age in seven of the eight subtests of the ECAB. The ECAB is a feasible battery in Italian as in the English version, for the assessment of early attention in preschool children, allowing the assessment of the different components of attention and a specific maturation follow up with increasing age.

Sections du résumé

BACKGROUND
The Early Childhood Attention Battery (ECAB) has been used to assess three different components of attention in preschool children, namely, selective, sustained and attentional control.
AIM
The aim of the study was: I) to adapt the ECAB to the Italian language; II) to collect Italian reference data using the translated version and III) to expand the available reference data using 6-month age intervals.
STUDY DESIGN
The adaptation of the ECAB to Italian language and the collection of Italian reference data was performed in four phases: translation and identification of the manual and subtests that needed adaptation; interobserver reliability and feasibility of the Italian version; application of the Italian ECAB; statistical analysis.
SUBJECTS
The ECAB was performed on a low risk population between 3 and 5 years, 11 months.
RESULTS
Statistical analysis was conducted subdividing the cohort in 6-month age groups. The final cohort included 300 low-risk typically developing children. The assessment was well accepted and enjoyed by most of the children except for some in the youngest group who refused to complete all of the tests. Our data showed a progressive improvement in attention across age in seven of the eight subtests of the ECAB.
CONCLUSION
The ECAB is a feasible battery in Italian as in the English version, for the assessment of early attention in preschool children, allowing the assessment of the different components of attention and a specific maturation follow up with increasing age.

Identifiants

pubmed: 32179328
pii: S0378-3782(19)30698-X
doi: 10.1016/j.earlhumdev.2020.105013
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

105013

Informations de copyright

Copyright © 2020 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest None.

Auteurs

Giorgia Coratti (G)

Pediatric Neurology Unit, Catholic University of Sacred Heart, Fondazione Policlinico Agostino Gemelli IRCCS, Rome, Italy.

Maria Mallardi (M)

Pediatric Neurology Unit, Catholic University of Sacred Heart, Fondazione Policlinico Agostino Gemelli IRCCS, Rome, Italy.

Carolina Coppola (C)

Pediatric Neurology Unit, Catholic University of Sacred Heart, Fondazione Policlinico Agostino Gemelli IRCCS, Rome, Italy.

Francesca Tinelli (F)

Department of Developmental Neuroscience, IRCCS Stella Maris Scientific Foundation, Calambrone, Pisa, Italy.

Mariaelisa Bartoli (M)

Department of Developmental Neuroscience, IRCCS Stella Maris Scientific Foundation, Calambrone, Pisa, Italy.

Valentina Laganà (V)

Regional Neurogenetic Centre ASP-CZ, Lamezia Terme, CZ, Italy.

Simona Lucibello (S)

Pediatric Neurology Unit, Catholic University of Sacred Heart, Fondazione Policlinico Agostino Gemelli IRCCS, Rome, Italy.

Serena Sivo (S)

Pediatric Neurology Unit, Catholic University of Sacred Heart, Fondazione Policlinico Agostino Gemelli IRCCS, Rome, Italy.

Francesca Gallini (F)

Pediatric Neurology Unit, Catholic University of Sacred Heart, Fondazione Policlinico Agostino Gemelli IRCCS, Rome, Italy; Department of Pediatrics, Catholic University of Sacred Heart, Fondazione Policlinico Agostino Gemelli IRCCS, Rome, Italy.

Domenico M Romeo (DM)

Pediatric Neurology Unit, Catholic University of Sacred Heart, Fondazione Policlinico Agostino Gemelli IRCCS, Rome, Italy.

Janette Atkinson (J)

Division of Psychology and Language Sciences, Faculty of Brain Sciences, University College London, London, UK.

Oliver Braddick (O)

Department of Experimental Psychology, University of Oxford, Oxford, UK.

Eugenio Mercuri (E)

Pediatric Neurology Unit, Catholic University of Sacred Heart, Fondazione Policlinico Agostino Gemelli IRCCS, Rome, Italy. Electronic address: eugeniomaria.mercuri@unicatt.it.

Daniela Ricci (D)

Pediatric Neurology Unit, Catholic University of Sacred Heart, Fondazione Policlinico Agostino Gemelli IRCCS, Rome, Italy; National Centre of Services and Research for the Prevention of Blindness and Rehabilitation of Low Vision Patients - IAPB Italia onlus, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH